Western blotting of lysates prepared from primary tumors (n = 16; WHO grades II–IV) and nonneoplastic brain tissue samples (n = 4) also confirmed PMEPA1 overexpression in human gliomas (Fig. 1c), but no significant correlation with IDH1 status. This evidence concerns the gene IDH1 and central nervous system cancer.